tradingkey.logo

Cytek Biosciences Inc

CTKB
4.470USD
-0.030-0.67%
Fechamento 02/06, 16:00ETCotações atrasadas em 15 min
571.56MValor de mercado
PerdaP/L TTM

Cytek Biosciences Inc

4.470
-0.030-0.67%

Mais detalhes de Cytek Biosciences Inc Empresa

Cytek Biosciences, Inc. is a cell analysis solutions company. The Company is advancing the cell analysis tools by delivering high-resolution, high-content, and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling (FSP) technology. Its platform includes its core FSP instruments, the Cytek Aurora and Northern Lights systems and the Cytek Aurora CS cell sorter; the Cytek Orion reagent cocktail preparation system; the Enhanced Small Particle (ESP) detection technology; the flow cytometer and imaging products under the Amnis and Guava brands, and reagents, software and service to provide a comprehensive and integrated suite of solutions for its customers. Its Cytek Aurora and Northern Lights systems are used in the study of infectious diseases, immunology, immunotherapy, immuno-oncology, oncology, and drug discovery. The Cytek Orion reagent cocktail preparation system enables researchers to fully automate the preparation of antibody cocktails for flow cytometry.

Informações de Cytek Biosciences Inc

Código da empresaCTKB
Nome da EmpresaCytek Biosciences Inc
Data de listagemJul 23, 2021
CEOJiang (Wenbin)
Número de funcionários648
Tipo de títulosOrdinary Share
Fim do ano fiscalJul 23
Endereço47215 Lakeview Boulevard
CidadeFREMONT
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal94538
Telefone18779229835
Sitehttps://cytekbio.com
Código da empresaCTKB
Data de listagemJul 23, 2021
CEOJiang (Wenbin)

Executivos da empresa Cytek Biosciences Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Ming Yan, Ph.D.
Dr. Ming Yan, Ph.D.
Co-Founder, Chief Technology Officer, Director
Co-Founder, Chief Technology Officer, Director
6.07M
+15908.00%
Dr. Wenbin Jiang, Ph.D.
Dr. Wenbin Jiang, Ph.D.
Chairman of the Board, President, Chief Executive Officer, Co-Founder
Chairman of the Board, President, Chief Executive Officer, Co-Founder
5.36M
+42235.00%
Ms. Valerie Barnett, J.D.
Ms. Valerie Barnett, J.D.
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
115.64K
+16490.00%
Dr. Vera Imper, Ph.D.
Dr. Vera Imper, Ph.D.
Independent Director
Independent Director
15.71K
+15706.00%
Ms. Deborah J. Neff
Ms. Deborah J. Neff
Lead Independent Director
Lead Independent Director
15.71K
+15706.00%
Mr. Michael Holder
Mr. Michael Holder
Independent Director
Independent Director
12.36K
+2181.00%
Mr. Jack T. Ball, Jr.
Mr. Jack T. Ball, Jr.
Independent Director
Independent Director
--
--
Mr. William (Bill) Mccombe
Mr. William (Bill) Mccombe
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Philippe Busque, Ph.D.
Dr. Philippe Busque, Ph.D.
Senior Vice President, Global Sales and Services
Senior Vice President, Global Sales and Services
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Ming Yan, Ph.D.
Dr. Ming Yan, Ph.D.
Co-Founder, Chief Technology Officer, Director
Co-Founder, Chief Technology Officer, Director
6.07M
+15908.00%
Dr. Wenbin Jiang, Ph.D.
Dr. Wenbin Jiang, Ph.D.
Chairman of the Board, President, Chief Executive Officer, Co-Founder
Chairman of the Board, President, Chief Executive Officer, Co-Founder
5.36M
+42235.00%
Ms. Valerie Barnett, J.D.
Ms. Valerie Barnett, J.D.
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
115.64K
+16490.00%
Dr. Vera Imper, Ph.D.
Dr. Vera Imper, Ph.D.
Independent Director
Independent Director
15.71K
+15706.00%
Ms. Deborah J. Neff
Ms. Deborah J. Neff
Lead Independent Director
Lead Independent Director
15.71K
+15706.00%
Mr. Michael Holder
Mr. Michael Holder
Independent Director
Independent Director
12.36K
+2181.00%

Detalhamento da receita

Moeda: USDAtualizado em: ter, 6 de jan
Moeda: USDAtualizado em: ter, 6 de jan
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
Biotechnology, pharmaceutical, distributor and CRO
34.50M
65.98%
Academia and government
17.79M
34.02%
Por RegiãoUSD
Nome
Receita
Proporção
United States
27.20M
52.02%
EMEA
12.38M
23.68%
APAC
11.14M
21.31%
Other
1.56M
2.99%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Biotechnology, pharmaceutical, distributor and CRO
34.50M
65.98%
Academia and government
17.79M
34.02%

Distribuição de ações

Atualizado em: seg, 2 de fev
Atualizado em: seg, 2 de fev
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
11.89%
The Vanguard Group, Inc.
5.85%
Topline Capital Management, LLC
5.43%
HHLR Advisors, Ltd.
5.21%
Yan (Ming)
4.75%
Outro
66.88%
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
11.89%
The Vanguard Group, Inc.
5.85%
Topline Capital Management, LLC
5.43%
HHLR Advisors, Ltd.
5.21%
Yan (Ming)
4.75%
Outro
66.88%
Tipos de investidores
Investidores
Proporção
Investment Advisor
28.70%
Investment Advisor/Hedge Fund
23.67%
Hedge Fund
9.87%
Individual Investor
9.31%
Research Firm
1.44%
Pension Fund
1.21%
Bank and Trust
0.18%
Family Office
0.12%
Venture Capital
0.06%
Outro
25.45%

Participação acionária institucional

Atualizado em: seg, 8 de dez
Atualizado em: seg, 8 de dez
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q4
319
80.93M
70.83%
-2.20K
2025Q3
325
80.93M
70.98%
+589.69K
2025Q2
322
80.49M
71.67%
+1.88M
2025Q1
319
78.68M
72.45%
-13.77M
2024Q4
315
78.50M
69.87%
+2.46M
2024Q3
291
75.89M
70.06%
-1.14M
2024Q2
277
76.97M
68.86%
-4.44M
2024Q1
273
87.08M
76.11%
-12.82M
2023Q4
268
85.37M
77.21%
+1.48M
2023Q3
258
83.84M
73.24%
+597.32K
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
BlackRock Institutional Trust Company, N.A.
15.20M
11.89%
-176.72K
-1.15%
Sep 30, 2025
The Vanguard Group, Inc.
6.93M
5.42%
-804.88K
-10.40%
Sep 30, 2025
Topline Capital Management, LLC
6.94M
5.43%
+1.71M
+32.75%
Sep 30, 2025
HHLR Advisors, Ltd.
6.66M
5.21%
--
--
Sep 30, 2025
Yan (Ming)
6.07M
4.75%
+15.91K
+0.26%
Nov 18, 2025
Jiang (Wenbin)
5.36M
4.19%
+42.23K
+0.79%
Nov 18, 2025
Brown Capital Management, LLC
4.96M
3.88%
-2.15M
-30.27%
Sep 30, 2025
State Street Investment Management (US)
4.08M
3.19%
-89.39K
-2.14%
Sep 30, 2025
Millennium Management LLC
3.42M
2.67%
+2.49M
+269.65%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
3.22M
2.52%
-237.02K
-6.86%
Sep 30, 2025
Ver Mais

ETFs Relacionados

Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
Invesco S&P SmallCap Health Care ETF
0.26%
Royce Quant Small-Cap Quality Value ETF
0.22%
iShares S&P Small-Cap 600 Value ETF
0.09%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.07%
State Street SPDR S&P 600 Small Cap Value ETF
0.06%
Avantis US Small Cap Equity ETF
0.05%
Invesco S&P SmallCap 600 QVM Multi-factor ETF
0.05%
Fidelity Enhanced Small Cap ETF
0.05%
Principal U.S. Small-Cap ETF
0.05%
WisdomTree US SmallCap Fund
0.04%
Ver Mais
Invesco S&P SmallCap Health Care ETF
Proporção0.26%
Royce Quant Small-Cap Quality Value ETF
Proporção0.22%
iShares S&P Small-Cap 600 Value ETF
Proporção0.09%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporção0.07%
State Street SPDR S&P 600 Small Cap Value ETF
Proporção0.06%
Avantis US Small Cap Equity ETF
Proporção0.05%
Invesco S&P SmallCap 600 QVM Multi-factor ETF
Proporção0.05%
Fidelity Enhanced Small Cap ETF
Proporção0.05%
Principal U.S. Small-Cap ETF
Proporção0.05%
WisdomTree US SmallCap Fund
Proporção0.04%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Data ex-dividendo
Tipo
Proporção
Sem dados
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
KeyAI